Amir Elstein - Teva Pharmaceutical Insider

Teva Pharmaceutical Industries Limited -- Mexico Stock  

MXN 280  2  0.71%

Vice Chairman of the Board

Mr. Amir Elstein serves as Director at Teva Pharmaceutical Industries Limited since January 2009. He is a member of the Science and Technology committees, Vice Chairman of the Finance and Investment committees and Chairman of the Corporationrationrate Governance and Nominating committees. His work experience includes the following roles Vice Chairman of the Board of Directors of Teva, Independent Director at the Company, Executive Vice President Global Pharmaceutical Resources at the Company, Director at the Company, Chairman of the Board of Tower Semiconductor Ltd., Chairman of the Board of Governors of the Jerusalem College of Engineering, Chairman of the Board of the Israel Democracy Institute, Chairman andor as a member of the board of directors of several academic, scientific, educational, social and cultural institutions, Chairman of the Board of Directors of Israel Corporationrationration and General Manager of Intel Electronics Ltd. . He holds a BS degree in Physics and Math, a MS degree in Solid State Physics and a Diploma of Senior Business Management, all from The Hebrew University of Jerusalem.
Age: 60  Chairman Since 2014      
972 3 926 7267  http://www.tevapharm.com
Elstein?s leadership positions in various international corporations, including his experience as a chairman in international public companies and his service as an executive officer at Teva and other companies, provides global business management and pharmaceutical expertise.

Management Efficiency

The company has return on total asset (ROA) of 4.73 % which means that it generated profit of $4.73 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of (19.12) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 35.05 B in total debt with debt to equity ratio (D/E) of 118.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Teva Pharmaceutical Industries Limited has Current Ratio of 0.92 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Entity Summary

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited (TEVAN) is traded on Mexico Stock Exchange in Mexico. It is located in Petach Tikva, and employs 42,888 people.

Did you try this?

Run Financial Widgets Now
   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Hide  View All  Next  Launch Financial Widgets
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Teva Pharmaceutical Industries Limited to your portfolio

Top Management

Teva Pharmaceutical Leadership Team
Moshe Many, Director, Ph.D
Roger Abravanel, Director, MBA
Eyal Desheh, President, MBA
Mark Sabag, President
Richard Lerner, Director, Ph.D
Galia Maor, Director, Ph.D
Carlo Notaristefani, CEO, Ph.D
Iris BeckCodner, President, MBA
JeanMichel Halfon, Director, MBA
Michael Hayden, President, Ph.D
Gabrielle Sulzberger, Director, MBA
Dipankar Bhattacharjee, President, MBA
Erez Vigodman, CEO
Yitzhak Peterburg, Director
Hafrun Fridriksdottir, President
Joseph Nitzani, Director, MBA
Timothy Wright, Executive
Isaac Abravanel, President
Sigurdur Olafsson, CEO
David Stark, Executive
Dan Propper, Director
Ory Slonim, Director
Kevin Mannix, President
Amir Elstein, Chairman
Kaare Schultz, CEO
Dan Suesskind, Director, MBA
Arie Belldegrun, Director, Ph.D
Richard Egosi, President, MBA
Sol Barer, Director, Ph.D
Jean Halfon, Director
Robert Koremans, CEO, Ph.D
Gerald Lieberman, Director
Rosemary Crane, Director, MBA

Stock Performance

Teva Pharmaceutical Performance Indicators